+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peripheral Embolic Protection Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 71 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5459966
Peripheral Embolic Protection Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Summary


This Medical Devices sector report, “Peripheral Embolic Protection Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Peripheral Embolic Protection Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Embolic Protection Device(s) EPDs are used to capture and remove plaque debris that are dislodged during interventional procedures. Peripheral Embolic Protection Devices (EPDs) used in the lower extremity, carotid and renal arteries have been accounted for. One unit refers to one EPD.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Peripheral Embolic Protection Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Peripheral Embolic Protection Devices Overview
3 Products under Development
3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment
3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory
3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials
4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies
4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
5 Peripheral Embolic Protection Devices Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 AorticLab Sarl Company Overview
5.2.1 AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview
5.3 Artio Medical Company Overview
5.3.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview
5.4 Avantec Vascular Corp Company Overview
5.4.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cardio-Flow Ltd. Company Overview
5.5.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Cardiovascular Systems Inc Company Overview
5.6.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Emboline, Inc. Company Overview
5.7.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Filterlex Medical Ltd Company Overview
5.8.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Innovative Cardiovascular Solutions, LLC Company Overview
5.9.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Innovia LLC Company Overview
5.10.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Instylla Inc Company Overview
5.11.1 Instylla Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Javelin Medical Ltd Company Overview
5.12.1 Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Keystone Heart Ltd Company Overview
5.13.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 Marblehead Medical LLC Company Overview
5.14.1 Marblehead Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 MicroPort CardioFlow Medtech Corp Company Overview
5.15.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview
5.16 MicroPort Scientific Corp Company Overview
5.16.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.17 MIV Therapeutics Inc Company Overview
5.17.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Neurosonix Ltd. Company Overview
5.18.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.19 Protembis GmbH Company Overview
5.19.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Minnesota Company Overview
5.20.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
6 Peripheral Embolic Protection Devices- Recent Developments
6.1 Oct 01, 2021: Inari Medical Appoints Dana G. Mead, Jr. to Board of Directors
6.2 Sep 21, 2021: Inari Medical Appoints Pulmonologist Dr. Victor F. Tapson as VP of Medical Affairs
6.3 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.4 Aug 26, 2021: Penumbra to Present at the 2021 Wells Fargo Virtual Healthcare Conference
6.5 Aug 10, 2021: Artio Medical's Solus Gold Embolization Device Featured at 2021 GEST Conference
6.6 Jul 29, 2021: Inari Medical to Present at the Canaccord Genuity 41st Annual Growth Conference
6.7 Jul 29, 2021: Edwards Lifesciences Announces financial results for the quarter ended June 30, 2021
6.8 Jul 28, 2021: Penumbra, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference
6.9 Jul 27, 2021: Inari Medical to Announce Second Quarter 2021 Financial Results
6.10 Jul 22, 2021: Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
6.11 Jul 13, 2021: AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
6.12 Jun 22, 2021: Inari Medical Appoints Outset Medical Executive Rebecca Chambers to Board of Directors
6.13 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.14 May 11, 2021: Inari Medical Reports First Quarter 2021 Financial Results
6.15 May 05, 2021: Edwards Announces Updates From Annual Meeting
6.16 Apr 29, 2021: Inari Medical to Present at the 2021 Bank of America Healthcare Conference
6.17 Apr 27, 2021: Inari Medical to Announce First Quarter 2021 Financial Results
6.18 Apr 13, 2021: Penumbra Schedules First Quarter 2021 Earnings Release and Conference Call for May 4, 2021
6.19 Mar 30, 2021: AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
6.20 Mar 08, 2021: U of M Vice President for Research Chris Cramer announces departure from the University for national research opportunity
6.21 Mar 01, 2021: AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
6.22 Feb 23, 2021: Penumbra, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
6.23 Feb 23, 2021: Inari Medical to Announce Fourth Quarter and Full Year 2020 Financial Results
6.24 Feb 17, 2021: U of M’s Technological Leadership Institute names Professor Allison Hubel new director
6.25 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.26 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.27 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.28 Feb 10, 2021: Penumbra, Inc. to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
6.29 Feb 03, 2021: Inari Medical to Present in Upcoming Investor Conferences
6.30 Feb 02, 2021: Penumbra, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 23, 2021
6.31 Jan 13, 2021: Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021
6.32 Jan 04, 2021: AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
6.33 Dec 08, 2020: Penumbra responds to false allegations from short sellers seeking to manipulate company stock and remove life-saving medical devices from the market
6.34 Oct 29, 2020: Inari Medical to Announce Third Quarter 2020 Financial Results
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
  • Peripheral Embolic Protection Devices - Pipeline Products by Segment
  • Peripheral Embolic Protection Devices - Pipeline Products by Territory
  • Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
  • Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
  • Peripheral Embolic Protection Devices - Ongoing Clinical Trials
  • Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
  • Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
  • Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status
  • Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description
  • AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview
  • EMBRACE - Product Status
  • EMBRACE - Product Description
  • AorticLab Sarl - Ongoing Clinical Trials Overview
  • EMBRACE - Clinical Study of a Novel Transcatheter Anti-embolic Filter (TAF) for Cerebral Protection During Aortic Valve Interventions
  • Artio Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Aneura Embolization Device - Product Status
  • Aneura Embolization Device - Product Description
  • Blockstent Microcatheter - Product Status
  • Blockstent Microcatheter - Product Description
  • Solus Flex Embolization Device - Product Status
  • Solus Flex Embolization Device - Product Description
  • Solus Gold Embolization Device - Product Status
  • Solus Gold Embolization Device - Product Description
  • Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Peripheral Embolization Device - Product Status
  • Peripheral Embolization Device - Product Description
  • Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • EmboPRO EPD - Product Status
  • EmboPRO EPD - Product Description
  • Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • WIRION EPD System - LE Atherectomy - Product Status
  • WIRION EPD System - LE Atherectomy - Product Description
  • Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Emboliner - Product Status
  • Emboliner - Product Description
  • Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • CAPTIS - Product Status
  • CAPTIS - Product Description
  • Filterlex Medical Ltd - Ongoing Clinical Trials Overview
  • CAPTIS - A Prospective, Single Arm, FIH Study to Evaluate the Safety and Feasibility of the CAPTIS Device in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR)
  • Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • EMBLOK Embolic Protection System - Product Status
  • EMBLOK Embolic Protection System - Product Description
  • Innovative Cardiovascular Solutions, LLC - Ongoing Clinical Trials Overview
  • EMBLOK Embolic Protection System - European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
  • Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Permanently Implantable Embolic Balloon - Product Status
  • Permanently Implantable Embolic Balloon - Product Description
  • Instylla Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Embrace Hydrogel Embolic System - Product Status
  • Embrace Hydrogel Embolic System - Product Description
  • Instylla Inc - Ongoing Clinical Trials Overview
  • Embrace Hydrogel Embolic System - Randomized Multi-center, Subject and Evaluator Blinded, Parallel-group Study to Evaluate the Safety and Effectiveness of the Instylla Hydrogel Embolic System (HES) Compared with Standard of Care Transcatheter Arterial Embolization (TAE) / Transcatheter Arterial Chemoembolization (cTACE) for Vascular Occlusion of Hypervascular Tumors: A Pivotal Study
  • Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Vine - Product Status
  • Vine - Product Description
  • Javelin Medical Ltd - Ongoing Clinical Trials Overview
  • Vine - Carotid Artery Implant for Trapping Upstream Emboli (CAPTURE 2) for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
  • Vine - Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients
  • Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • TriGuard 3 Cerebral Embolic Protection Device - Product Status
  • TriGuard 3 Cerebral Embolic Protection Device - Product Description
  • Marblehead Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • FFRACAS Device - Product Status
  • FFRACAS Device - Product Description
  • MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Embolic Protection Device - TAVI - Product Status
  • Embolic Protection Device - TAVI - Product Description
  • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Arterial Micro-Embolic Filter - Product Status
  • Arterial Micro-Embolic Filter - Product Description
  • MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Aortic Embolic Protection Device - Product Status
  • Aortic Embolic Protection Device - Product Description
  • Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Protection Collar - Product Status
  • Protection Collar - Product Description
  • Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • ProtEmbo System - Product Status
  • ProtEmbo System - Product Description
  • Protembis GmbH - Ongoing Clinical Trials Overview
  • ProtEmbo System - Cerebral Protection in Transcatheter Aortic Valve Replacement - The PROTEMBO C Trial
  • University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • Embolic Protection Device - Product Status
  • Embolic Protection Device - Product Description
  • Glossary

List of Figures
  • Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
  • Peripheral Embolic Protection Devices - Pipeline Products by Segment
  • Peripheral Embolic Protection Devices - Pipeline Products by Territory
  • Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
  • Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
  • Peripheral Embolic Protection Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Vascular Inc
  • AorticLab Sarl
  • Artio Medical
  • Avantec Vascular Corp
  • Cardio-Flow Ltd.
  • Cardiovascular Systems Inc
  • Emboline, Inc.
  • Filterlex Medical Ltd
  • Innovative Cardiovascular Solutions, LLC
  • Innovia LLC
  • Instylla Inc
  • Javelin Medical Ltd
  • Keystone Heart Ltd
  • Marblehead Medical LLC
  • MicroPort CardioFlow Medtech Corp
  • MicroPort Scientific Corp
  • MIV Therapeutics Inc
  • Neurosonix Ltd.
  • Protembis GmbH
  • University of Minnesota